Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Description

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.

Conditions

Diabetes

Talk to us

Study Overview

On this page

Study Details

Study overview

This is a randomized, placebo-controlled trial that will test the efficacy of VPNP in reducing HbA1c. Participant recruitment will occur through direct-to-participant enrollment. No additional clinical sites will be used for recruitment.

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Efficacy of Viome's Precision Nutrition Program Towards Reducing HbA1c

Condition
Diabetes
Intervention / Treatment

-

Contacts and Locations

Bothell

Viome Life Sciences, Bothell, Washington, United States, 98011

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Signed and dated informed consent form and medical release prior to any trial-specific procedures are performed
  • * Females and males aged 18 years or older
  • * Able to speak and read English
  • * HbA1c between 6.5-8.9% (inclusive), tested within the past 30 days
  • * Willing and able to visit a Quest Diagnostic Patient Service Center (PSC)
  • * Willing and able to follow the trial instructions and Viome's Precision Nutrition Program
  • * Willing and able to use a smartphone and Viome app.
  • * Antibiotic use within one month of the GI test
  • * Gestation within previous 6 month
  • * Current (or previous) use of medications that increase insulin (sulfonylureas, such as glimepiride, glipizide, glyburide, etc.)
  • * Current (or previous) use of exogenous insulin (such as Tresiba, Lantus, Toujeo, Levemir, Humalog, Novolog, Apidra, Fiasp, etc.)
  • * On a specific diet, such as ketogenic, for the purpose of reducing HbA1c and/or weight within the previous month
  • * Taking diet pills
  • * Allergy to an ingredient in the MH capsule or stick pack
  • * Currently on an investigational product
  • * Significant surgery or medical procedure planned
  • * Diet or lifestyle change during the trial period, besides those appropriate for trial arm Has followed Viome nutritional recommendations (foods and/or supplements)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Viome,

Momchilo Vuyisich, PRINCIPAL_INVESTIGATOR, Viome

Study Record Dates

2025-09